By Carlos Méndez and Chris Thomas Feb 5 (Reuters) - The U.S. Food and Drug Administration (FDA) will take swift action against companies that mass-market "illegal copycat drugs" by claiming they are ...

For decades Americans have spent more on prescription drugs than people in other countries. The Biden Administration has been involved in ongoing efforts to stem this trend, making prescription drugs ...

If compounded and generic GLP-1 drugs work as well as brand-name versions, they could fill a significant void by offering personalized dosing and greater affordability.

The FDA said on Friday it plans to restrict GLP-1 ingredients used in non-approved compounded drugs from companies like Hims & Hers.

Section 1. Purpose. My first term included numerous significant actions, including some of the most aggressive in recent history, to deliver lower prescription drug prices to American patients. The ...

WASHINGTON — President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy.

Section 1. Purpose. The United States has less than five percent of the world’s population and yet funds around three quarters of global pharmaceutical profits. This egregious imbalance is ...

NPR's Leila Fadel talks to Lina Khan, chair of the Federal Trade Commission, about drug companies holding patents on medications for much longer than they're supposed to. Most drug patents are meant ...